ºÚÁÏÍø

PI-RADS

Standards to improve early diagnosis and treatment of prostate cancer

ºÚÁÏÍø Prostate Reporting and Data System (PI-RADS)

Current Release

PI-RADS 2019 v2.1 is available on the web.

To expedite the transfer of high-quality MRI from laboratories to patients to help improve early diagnosis of clinically significant prostate cancer and reduce unnecessary biopsies and treatment for benign and subclinical diseases.


Further reading:

  • PI-RADS v2.1 Report Template:  |

Request Permission for PI-RADS

PI-RADS Archive

PI-RADS v2 Module

Using PI-RADS v2.1 for Prostate MRIEducation Activity

Primer for Using PI-RADS v2.1 for Prostate MRI

This educational activity was developed to provide radiologists with basic information about prostate MRI acquisition, interpretation and reporting.

The activity is divided into seven sections that can be reviewed linearly or nonlinearly to facilitate self-paced learning. Illustrative examples are used to describe normal prostate anatomy, the PI-RADS assessment categories, prostate cancer staging and caveats for imaging interpretation.

The basic elements of a structured prostate MRI report and the technical standards for image acquisition described in PI-RADS v2.1 are also reviewed. At the end of each section, important concepts are reviewed in knowledge checks. Links to supporting documents and other resources are provided at the end of the activity.

Learning Objectives

  1. Outline the principles of PI-RADS v2.1 and the scoring system during the interpretation of mpMRI of the prostate.
  2. Describe caveats for the interpretation of prostate cancer mimickers.
  3. Demonstrate how to report imaging findings using the standardized format.
  4. Cite ways to optimize prostate imaging protocols using the mpMRI principles to achieve the best diagnostic performance.

In order to successfully complete the activity participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.

The ºÚÁÏÍø (ºÚÁÏÍø®) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ºÚÁÏÍø are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ºÚÁÏÍø in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ºÚÁÏÍø to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ºÚÁÏÍø.

The following planners and managers have no relevant financial relationships to disclose:Lauren Attridge, Cassandra Vivian-Davis, Valerie Kasdan, Maddy Gerhart, Julie Bauml, MD

The planners have the following identified relevant financial relationships: Katarzyna J. Macura, MD, PhD, FºÚÁÏÍø — Contracted Research: Profound Medical Corp.; Stock Shareholder: Intuitive Surgical Inc.

The faculty members (speakers, etc.) have the following identified relevant financial relationships: Andrei S. Purysko, MD — Contracted Research: Lantheus (research support)

Designation Statement

The ºÚÁÏÍø designates this enduring activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Accreditation Statement

The ºÚÁÏÍø is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Released:11/13/2024
CME Expires: 11/13/2027

For information about the accreditation of this program, please contact the ºÚÁÏÍø.

Licensing RADS content

License Information

Reporting and Data Systems (RADS) by the ºÚÁÏÍø are licensed under a . Permissions beyond the scope of this license may be available by using our . Contact us: rads@acr.org

Related Resources

  • European Urology

    Letter to the Editor of European Urology Journal Regarding PI-RADS

  • Radiology

    PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway

  • European Urology

    Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

  • JºÚÁÏÍø

    ºÚÁÏÍø Stakeholder Prostate Summit